-
Product Insights
Likelihood of Approval Analysis for Acne And Related Disorders
Overview How likely is it that the drugs in Acne And Related Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acne And Related Disorders Overview Acne and related disorders encompass...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AMTX-100 in Atopic Dermatitis (Atopic Eczema)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AMTX-100 in Atopic Dermatitis (Atopic Eczema) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AMTX-100 in Atopic Dermatitis (Atopic Eczema) Drug Details: AMTX-100 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Afamelanotide Acetate in Vitiligo
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Afamelanotide Acetate in Vitiligo report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Afamelanotide Acetate in Vitiligo Drug Details: Afamelanotide (Scenesse) is an analog...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Afamelanotide Acetate in Acne Vulgaris
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Afamelanotide Acetate in Acne Vulgaris report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Afamelanotide Acetate in Acne Vulgaris Drug Details: Afamelanotide (Scenesse) is an...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Afamelanotide Acetate in Acute Ischemic Stroke
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Afamelanotide Acetate in Acute Ischemic Stroke report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Afamelanotide Acetate in Acute Ischemic Stroke Drug Details: Afamelanotide (Scenesse)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LUT-014 in Acne And Related Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LUT-014 in Acne And Related Disorders report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.LUT-014 in Acne And Related Disorders Drug Details:LUT-014 is under development...
-
Product Insights
Net Present Value Model: Retin-A Franchise
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Retin-A Franchise Drug Details Tretinoin (Retin-A,...